These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 31080107)
41. The improved antibody response against HIV-1 after a vaccination based on intrastructural help is complemented by functional CD8+ T cell responses. Storcksdieck genannt Bonsmann M; Niezold T; Hannaman D; Überla K; Tenbusch M Vaccine; 2016 Apr; 34(15):1744-51. PubMed ID: 26945099 [TBL] [Abstract][Full Text] [Related]
42. Recent strategies targeting HIV glycans in vaccine design. Horiya S; MacPherson IS; Krauss IJ Nat Chem Biol; 2014 Dec; 10(12):990-9. PubMed ID: 25393493 [TBL] [Abstract][Full Text] [Related]
44. Elucidating the elite: mechanisms of control in HIV-1 infection. O'Connell KA; Bailey JR; Blankson JN Trends Pharmacol Sci; 2009 Dec; 30(12):631-7. PubMed ID: 19837464 [TBL] [Abstract][Full Text] [Related]
45. Current views on the potential for development of a HIV vaccine. Cohen KW; Frahm N Expert Opin Biol Ther; 2017 Mar; 17(3):295-303. PubMed ID: 28095712 [TBL] [Abstract][Full Text] [Related]
46. Prospects for a globally effective HIV-1 vaccine. Excler JL; Robb ML; Kim JH Vaccine; 2015 Nov; 33 Suppl 4():D4-12. PubMed ID: 26100921 [TBL] [Abstract][Full Text] [Related]
47. Architectural insight into inovirus-associated vectors (IAVs) and development of IAV-based vaccines inducing humoral and cellular responses: implications in HIV-1 vaccines. Hassapis KA; Stylianou DC; Kostrikis LG Viruses; 2014 Dec; 6(12):5047-76. PubMed ID: 25525909 [TBL] [Abstract][Full Text] [Related]
48. T cell immune responses to HIV-1. Vasan S; Schlesinger SJ; Arrode G Front Biosci; 2007 Jan; 12():2330-43. PubMed ID: 17127243 [TBL] [Abstract][Full Text] [Related]
49. Emerging concepts on the role of innate immunity in the prevention and control of HIV infection. Ackerman ME; Dugast AS; Alter G Annu Rev Med; 2012; 63():113-30. PubMed ID: 22077718 [TBL] [Abstract][Full Text] [Related]
51. A novel respiratory syncytial virus (RSV) F subunit vaccine adjuvanted with GLA-SE elicits robust protective TH1-type humoral and cellular immunity in rodent models. Lambert SL; Aslam S; Stillman E; MacPhail M; Nelson C; Ro B; Sweetwood R; Lei YM; Woo JC; Tang RS PLoS One; 2015; 10(3):e0119509. PubMed ID: 25793508 [TBL] [Abstract][Full Text] [Related]
52. Obstacles to the successful development of an efficacious T cell-inducing HIV-1 vaccine. Haut LH; Ertl HC J Leukoc Biol; 2009 Oct; 86(4):779-93. PubMed ID: 19597003 [TBL] [Abstract][Full Text] [Related]
53. A brief history of the global effort to develop a preventive HIV vaccine. Esparza J Vaccine; 2013 Aug; 31(35):3502-18. PubMed ID: 23707164 [TBL] [Abstract][Full Text] [Related]